Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 246 participants.
Also called NCT06980753
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 246 participants
- Sponsor
- Registry
-
NCT06980753
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06980753. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-06-01 (anticipated); primary completion 2025-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders
- Condition
- Cushing Syndrome
- Condition
- Primary Aldosteronism
- Condition
- Adrenal Insufficiency
- Intervention (Device)
- Participants will use the biossensor for 48 h
- Lead sponsor
- University of Sao Paulo General Hospital
- Collaborator
- Swiss Federal Institute of Technology in Zurich (ETH Zurich)
- Collaborator
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Record details
- Record id
cardio:ct-nct06980753- Content hash
b0eb563eccc1c10b39790b622d915abbbf077ad3d7de319618cc332cd6594df3